Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq

Background and objectives: Lymphoproliferative neoplasms are among the commonest human neoplasia. Immune dysregulation is frequently associated with many of these diseases, particularly those related to B-cell origin. This study aimed to find out the immunological status of newly diagnosed patients...

Full description

Bibliographic Details
Main Authors: Karwan Bahram Maulood, Abdulkadir Aziz Alnaqshabandi
Format: Article
Language:English
Published: Hawler Medical University 2017-12-01
Series:Zanco Journal of Medical Sciences
Subjects:
Online Access:http://zjms-hmu.org/files/articles/281217030656.pdf
_version_ 1818827362707439616
author Karwan Bahram Maulood
Abdulkadir Aziz Alnaqshabandi
author_facet Karwan Bahram Maulood
Abdulkadir Aziz Alnaqshabandi
author_sort Karwan Bahram Maulood
collection DOAJ
description Background and objectives: Lymphoproliferative neoplasms are among the commonest human neoplasia. Immune dysregulation is frequently associated with many of these diseases, particularly those related to B-cell origin. This study aimed to find out the immunological status of newly diagnosed patients with lymphoproliferative disorders. Methods: This study was carried out in Erbil province during the period from November 2010 to April 2011. Fifty two newly diagnosed patients (34 males and 18 females) with lymphoproliferative disorders referred to Nnakaly Hospital for blood disease and 20 healthy control subjects had been included in this study. Determination of immunoglobulin subclasses by radial immunodiffusion in addition serum protein electrophoresis has been performed for each sample for the detection of monoclonal bands. Results: Serum IgM and IgA level were decreased in all groups of patients with different lymphoproliferative disorders compared to control group. Serum IgG level showed insignificant reduction in acute lymphocytic leukemia and chronic lymphocytic leukemia patients, but it was increased in non Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma patients. Paraproteinemia had been seen in all patients with multiple myeloma while only 10% of chronic lymphocytic leukemia and non Hodgkin lymphoma showed paraproteinemia. No M-band had been noticed in acute lymphocytic leukemia and Hodgkin lymphoma. Conclusion: There were some conflicting data regarding serum immunoglobulin levels in newly diagnosed patients with lymphoproliferative disorders in Erbil, Iraq.
first_indexed 2024-12-19T00:42:21Z
format Article
id doaj.art-c26f0e87115340fd8b66056c6d14589a
institution Directory Open Access Journal
issn 1995-5588
1995-5596
language English
last_indexed 2024-12-19T00:42:21Z
publishDate 2017-12-01
publisher Hawler Medical University
record_format Article
series Zanco Journal of Medical Sciences
spelling doaj.art-c26f0e87115340fd8b66056c6d14589a2022-12-21T20:44:29ZengHawler Medical UniversityZanco Journal of Medical Sciences1995-55881995-55962017-12-012131930193710.15218/zjms.2017.053Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, IraqKarwan Bahram Maulood0Abdulkadir Aziz Alnaqshabandi1Erbil Directorate of HealthHawler Medical UniversityBackground and objectives: Lymphoproliferative neoplasms are among the commonest human neoplasia. Immune dysregulation is frequently associated with many of these diseases, particularly those related to B-cell origin. This study aimed to find out the immunological status of newly diagnosed patients with lymphoproliferative disorders. Methods: This study was carried out in Erbil province during the period from November 2010 to April 2011. Fifty two newly diagnosed patients (34 males and 18 females) with lymphoproliferative disorders referred to Nnakaly Hospital for blood disease and 20 healthy control subjects had been included in this study. Determination of immunoglobulin subclasses by radial immunodiffusion in addition serum protein electrophoresis has been performed for each sample for the detection of monoclonal bands. Results: Serum IgM and IgA level were decreased in all groups of patients with different lymphoproliferative disorders compared to control group. Serum IgG level showed insignificant reduction in acute lymphocytic leukemia and chronic lymphocytic leukemia patients, but it was increased in non Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma patients. Paraproteinemia had been seen in all patients with multiple myeloma while only 10% of chronic lymphocytic leukemia and non Hodgkin lymphoma showed paraproteinemia. No M-band had been noticed in acute lymphocytic leukemia and Hodgkin lymphoma. Conclusion: There were some conflicting data regarding serum immunoglobulin levels in newly diagnosed patients with lymphoproliferative disorders in Erbil, Iraq.http://zjms-hmu.org/files/articles/281217030656.pdfLymphoproliferative disordersImmunoglobulinParaprotein
spellingShingle Karwan Bahram Maulood
Abdulkadir Aziz Alnaqshabandi
Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq
Zanco Journal of Medical Sciences
Lymphoproliferative disorders
Immunoglobulin
Paraprotein
title Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq
title_full Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq
title_fullStr Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq
title_full_unstemmed Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq
title_short Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq
title_sort serum immunoglobulin levels in patients with lymphoproliferative diseases in erbil kurdistan region iraq
topic Lymphoproliferative disorders
Immunoglobulin
Paraprotein
url http://zjms-hmu.org/files/articles/281217030656.pdf
work_keys_str_mv AT karwanbahrammaulood serumimmunoglobulinlevelsinpatientswithlymphoproliferativediseasesinerbilkurdistanregioniraq
AT abdulkadirazizalnaqshabandi serumimmunoglobulinlevelsinpatientswithlymphoproliferativediseasesinerbilkurdistanregioniraq